Memantine Tablet
Memantine is a compounded formulation containing Memantine, prepared by Mixlab for veterinary use. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Memantine is an NMDA receptor antagonist utilized in veterinary medicine primarily for the management of behavioral and neurological challenges. It is a prescription medication available for use in dogs and cats, requiring a valid veterinarian-client-patient relationship before it can be dispensed. It is frequently considered in the context of behavioral health for managing compulsive behaviors or cognitive dysfunction.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is considered to influence the central nervous system by addressing the overstimulation of NMDA receptors by glutamate. Commonly observed effects include behavioral shifts such as temporary lethargy, coordination changes or restlessness. Because it influences neurological signaling, your veterinarian will monitor for observational signs of sensitivity, particularly in pets with known renal impairment. Owners should monitor for significant changes in activity or appetite and contact their veterinarian promptly with any concerns regarding the patient's response to the medication.
Yes. Memantine is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal authorizations before any medication is prepared.
Yes. Mixlab specializes in compounding memantine into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to suit the specific needs of your pet.
Veterinarians discuss memantine because it is considered to influence the signals in the brain that may contribute to compulsive or reactive behaviors. This provides a method for addressing your pet's behavioral responses during recovery.
Lethargy and coordination changes are commonly observed effects. Your veterinarian will provide guidance on what level of drowsiness is expected and how to monitor your pet's energy levels during use.
Veterinarians may discuss memantine for senior pets presented with cognitive shifts. Your veterinarian will determine the clinical appropriateness based on your pet's individual diagnostic and behavioral profile.
